Risedronate sodium
产品价格
| 产品编号 | 品牌 | 包装单位 | 单价(元) | 现货 |
| 3215533 | Sigma-Aldrich | 50 MG | 1390 | 请咨询 |
| 3523112 | J&K | 250MG | 2630 | 请咨询 |
| 3523112 | J&K | 50MG | 832 | 请咨询 |
| 4056450 | Alfa Aesar | 1g | 8960 | 请咨询 |
| 4056450 | Alfa Aesar | 250mg | 2950 | 请咨询 |
结构式
 |
基本信息
| Empirical Formula【经验(实验)分子式】 | C7H10NO7P2 · Na |
| Molecular weight | 305.09 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | Risedronate sodium is a bisphosphonate bone resorption inhibitor. It has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent and is an inhibitor of farnesyl diphosphate (FPP) synthase, which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. Risedronate sodium has been used to treat postmenopausal osteoporosis and Paget′s disease. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥97% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to beige |
| solubility【溶解性】 | H2O: 5 mg/mL, clear (warmed) |
| storage temp.【储存温度】 | room temp |
| packaging【包装】 | 50 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 + H312 + H332 |
| Precautionary Statements | P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |